Bicycle Day and the First LSD Trip: The Story Behind April 19th

On the afternoon of April 19, 1943, a 37-year-old Swiss chemist swallowed a quarter milligram of a compound he'd made in his lab five years earlier, climbed onto a bicycle, and pedaled into one of the most consequential drug experiences in human history.

That chemist was Albert Hofmann. The compound was LSD-25. And the afternoon bike ride that followed, terrifying, beautiful, and unlike anything previously documented in pharmacology, would eventually give its name to an unofficial international holiday, spark decades of scientific research, fuel an entire counterculture, and set the stage for a clinical renaissance that's still unfolding today.

This is the story of Bicycle Day, from Hofmann's lab bench in Basel to the modern psychedelic landscape and why it matters whether you're a researcher, a casual observer, or someone who just wants to know what their tab actually is.

Who Was Albert Hofmann?

Albert Hofmann grew up near Baden, Switzerland, where he spent much of his childhood wandering forests and developing a fascination with the natural world. That fascination led him to chemistry. He earned his doctorate in medicinal chemistry from the University of Zurich in 1929, then took a research position at Sandoz Pharmaceuticals in Basel.

By the mid-1930s, Hofmann was deep into a systematic study of ergot alkaloids, compounds produced by Claviceps purpurea, a parasitic fungus that infects rye grain. Ergot had a long and dark history in Europe. Outbreaks of ergotism, caused by consuming contaminated bread, had ravaged communities for centuries, producing gangrene, convulsions, and hallucinations. But within that toxic fungus, Hofmann saw pharmaceutical potential. Ergot derivatives were already being used in obstetrics and migraine treatment. He believed the core molecule, lysergic acid, could yield new medicines.

He was right, just not in the way he expected.

The Discovery of LSD-25

In 1938, Hofmann synthesized the 25th compound in his lysergic acid series: lysergic acid diethylamide, or LSD-25. He hoped it might stimulate respiration and circulation. Sandoz tested it on animals. The results were unremarkable, some agitation in mice, a contraction effect on uterine tissue, nothing that warranted further investigation.

LSD-25 was filed away. For five years, it existed only as a line item in a lab notebook. No one at Sandoz had any reason to think about it again.

The First Accidental LSD Experience

But Hofmann did think about it. In 1943, he revisited LSD-25, driven by what he later described as an unusual intuition, a persistent sense that the compound deserved another look. This was unusual for a methodical, conservative scientist. Hofmann wasn't the type to chase hunches. But something about LSD-25 wouldn't leave him alone.

On April 16, 1943, a Friday, he synthesized a new batch. During the final steps of purification, he began feeling odd. A growing restlessness. Dizziness. An inability to concentrate. He left the lab early and went home, where he lay down and closed his eyes.

What followed was unexpected: a cascade of vivid, shifting imagery, fantastic shapes and colors streaming past in an unbroken flow, accompanied by a heightened, almost electric quality of perception. It lasted roughly two hours and faded without incident.

Hofmann was a meticulous researcher, and he was baffled. He suspected he had absorbed a trace amount of LSD-25 through his skin during the synthesis. The only way to confirm it was to test the compound on purpose.

April 19, 1943, 4:20 PM: The First Intentional Acid Trip

Three days later, Hofmann prepared 250 micrograms of LSD-25 in a glass of water and drank it at precisely 4:20 PM. He chose that dose because he believed it was extremely small, a cautious starting point. He was wrong. What he considered a minimal amount turns out to be roughly five to ten times what's now understood as a moderate dose of LSD. No one in 1943 had any frame of reference for a substance active at the microgram level.

By 5:00 PM, his lab journal entries were deteriorating. Dizziness. Anxiety. Visual disturbance. A desire to laugh that felt involuntary and strange. Within minutes, writing was impossible.

Hofmann asked his laboratory assistant to take him home. Wartime Basel had banned private automobile use, so the only option was a bicycle.

The Bicycle Ride That Named a Holiday

The bicycle ride from Sandoz Labs to Hofmann's home is the centerpiece of Bicycle Day, and for good reason. What happened on that ride encapsulated everything LSD would come to represent: the loss of control, the warping of ordinary reality, the simultaneous terror and wonder of a mind unmoored from its default settings.

Hofmann later described the journey in vivid detail. His visual field was distorted as if reflected through a curved mirror. He felt paralyzed, unable to move, yet his assistant told him afterward that they had been traveling at considerable speed. Familiar streets looked alien. Time stretched and compressed unpredictably.

By the time he reached home, he was in the grip of a full-blown psychedelic crisis. He was convinced he had been poisoned. He believed he was dying. His neighbor appeared to him as a malevolent witch. He felt his sense of self dissolving.

A doctor was summoned. Remarkably, Hofmann's vital signs were largely normal, elevated heart rate, massively dilated pupils, but nothing that pointed to a medical emergency. There was no antidote to administer. There was nothing to do but ride it out.

What an LSD Trip Actually Felt Like

Hours into the experience, the terror subsided. What replaced it was something Hofmann struggled to articulate for the rest of his life, a sense of overwhelming beauty, interconnection, and renewal. Colors became impossibly vivid. Sounds took on a visual dimension. The ordinary world looked extraordinary.

By the next morning, Hofmann felt not just recovered but revitalized. He described a sensation of seeing the world with fresh eyes, as if for the first time. He had confirmed what he needed to confirm: LSD-25 was psychoactive at doses so small they defied pharmacological convention.

He had also, without knowing it, set something enormous into motion.

How LSD Changed the World

What happened after Bicycle Day is its own sprawling history. Sandoz began distributing LSD to researchers under the trade name Delysid in 1947. Through the 1950s, over a thousand clinical papers were published exploring LSD's therapeutic potential, for alcoholism, anxiety, depression, and end-of-life distress. The CIA got involved, running covert experiments through MK-ULTRA. Psychiatrists used it in private practice. Timothy Leary turned it into a countercultural rallying cry. By 1968, the United States had criminalized it.

In a single generation, LSD went from unknown lab compound to world-altering cultural force to Schedule I controlled substance. Hofmann watched all of it happen and spent his later decades caught between pride in the discovery and anguish over its misuse. He called LSD his "problem child"—brilliant and dangerous in equal measure.

He also lived to be 102, passing away in 2008 in the same city where he'd made that bicycle ride 65 years earlier.

LSD in Clinical Research Today

If Hofmann were alive today, he'd likely be stunned, and probably cautiously optimistic, about what's happening with the compound he created.

LSD is back in clinical research for the first time in decades, and the results are serious. MindMed received FDA Breakthrough Therapy Designation for MM120, a pharmaceutical-grade LSD formulation, and dosed the first patient in a Phase 3 trial for major depressive disorder in April 2025. A recent Phase 2 trial for generalized anxiety disorder showed rapid, sustained improvement after a single dose. Meanwhile, an open-label study published in Neuropharmacology found that even microdosed LSD produced significant, lasting reductions in depression symptoms.

Psychedelic science more broadly is experiencing its most productive era since the 1960s. Compass Pathways hit its primary endpoint in a Phase 3 psilocybin trial for treatment-resistant depression in 2025. Institutions from Johns Hopkins to UCSF to Imperial College London are actively researching how psychedelics reshape brain connectivity and disrupt pathological mental patterns.

The compound that got shelved, forgotten, rediscovered by accident, and then banned for decades is now being investigated as a potential frontline treatment for some of the most treatment-resistant conditions in psychiatry.

Why Testing LSD Still Matters

For all the progress in clinical research, the reality of the unregulated psychedelic market in 2026 is the same as it's been for decades: what you buy is not always what you get.

Tabs and blotter paper sold as LSD can contain NBOMe compounds, DOx-series substances, or various research chemicals. Some of these carry significantly higher physical risk than LSD, particularly the NBOMe family, which has been linked to seizures, hospitalizations, and deaths at doses that would be unremarkable for actual LSD. Others may be LSD prodrugs like 1P-LSD or 1cP-LSD, which are pharmacologically similar but vary in potency and legal status.

The fundamental problem hasn't changed since 1943: you're dealing with substances that are active at quantities invisible to the naked eye. You can't see it, smell it, or taste it. Without testing, you're guessing.

How to Test LSD

Reagent testing is the most accessible first step. It won't tell you how many micrograms are on a tab, but it can tell you whether what you have is consistent with an indole-based psychedelic like LSD, or whether it's something else entirely.

The Ehrlich Test (The First-Line Screen)

The Ehrlich reagent is the first-line screen. It reacts with indole-containing compounds, including LSD and most lysergamides, producing a purple color change. No purple means no indole, which means it's not LSD.

The Hofmann Test (Additional Specificity)

The Hofmann reagent provides additional screening specificity for lysergamide-type compounds, helping to narrow the identification further. Running both Ehrlich and Hofmann together gives you a solid baseline panel.

At-Home Potency Testing

To discover purity, how many micrograms of LSD are in each square of blotter, drop of liquid, or sugar cube, you can use the LSD QTest Kit for at-home testing.

Laboratory Analysis

For definitive identification, exact compound, exact dose, laboratory analysis via GC-MS or LC-MS is the standard. This is the only way to know precisely what's on a tab and how much of it is there.

See our full library of reaction videos for a visual guide: Reaction Video Library

What Bicycle Day Means Today

Bicycle Day isn't just a quirky psychedelic holiday. It marks the moment a careful, conservative scientist did something radical, he tested an unknown substance on himself, documented what happened with unflinching honesty, and changed the world in the process.

The holiday was first named in 1985 by Thomas B. Roberts, a professor at Northern Illinois University, who chose the bicycle as the symbol because it was vivid and concrete, and because it drew a parallel to Paul Revere's ride at the start of another revolution.

More than 80 years later, the questions Hofmann's ride raised are still the ones that matter most. What are psychedelics capable of? What are the risks? And how do we engage with powerful substances responsibly, with curiosity, with caution, respect, and with as much information as we can get before we commit?

The best way to honor the spirit of Bicycle Day is the same thing Hofmann would tell you: know what you're working with before you begin.

Related Resources

Learn more about testing LSD and psychedelic safety:

• How to Test LSD – Complete testing guide with recommended kit packages
• How to Test for Fentanyl – Critical first step before testing any substance
• Reaction Video Library – Watch real-time reagent reactions to compare with your tests
• Ehrlich Reaction Booklet – Color guide for interpreting Ehrlich reagent results
• Hofmann Reaction Booklet – Color guide for interpreting Hofmann reagent results
• QTest Purity Test Kit Basics – How quantitative potency testing works
• Transparency Testing Lab Services – Mail-in GC-MS and LC-MS analysis
• Our Types of Test Kits – Understanding the different testing methods available

Sources

• Hofmann, A. (1980). LSD: My Problem Child. McGraw-Hill.
• Hofmann, A. (1970). The Discovery of LSD and Subsequent Investigations on Naturally Occurring Hallucinogens. Discoveries in Biological Psychiatry.
• Roberts, T.B. (2006). Interview on the origin of Bicycle Day. Northern Illinois University.
• Wikipedia: Bicycle Day (psychedelic holiday)
• Daldegan-Bueno, D. et al. (2026). LSD microdosing in major depressive disorder: results from an open-label trial. Neuropharmacology, 283, 110762.
• MindMed (2025). First Patient Dosed in Phase 3 Emerge Study of MM120 in Major Depressive Disorder. Press release.
• Compass Pathways (2025). COMP005 Phase 3 Trial Results in Treatment-Resistant Depression.
• MDPI Pharmaceuticals (2025). Clinical Research on Lysergic Acid Diethylamide (LSD) in Psychiatry and Neuroscience.
• Pearl Psychedelic Institute (2025). The Meaning and Significance of Bicycle Day.
• Rolling Stone (2020). This Bicycle Day, Celebrate Albert Hofmann's Psychedelic Discovery.